Expanding Innovations, Inc.
USPTO PatentsView assignee record - 6 granted patents across 2 technology areas, recorded in grant years 2018–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).
The verdict
According to USPTO PatentsView, Expanding ranks #40,141 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 2 technology areas.
- #40,141
- of 49,997 US assignees by volume
- Top 34%
- by Innovation Score (41.2/100)
- 15.8
- avg claims per patent
- +100%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R40141 · US Corporation #40,141 · 6 grants
GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL
- GRANTS-MICRO 6 grants
- LOWER-Q #40,141/49,997
- PHOTO-FINISH Exaptive
- CPC-NARROW A61F · 2 areas
- INNOV-PAR 41.2/100
- CLAIMS-RICH 15.8 claims/avg
- TYPE-USCORP US Corporation
- VEL-SURGE +100% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Exaptive, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Expanding’s 41.2 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Expanding
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Expanding Innovations · this assignee
Expanding Innovations · this assignee
41 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Expanding's Innovation Score is 41.2/100 (top 34% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Expanding?
Each dot is one of Expanding’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Expanding’s own 15.8 claims/patent is at or below the 16.3 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Expanding's grants concentrate
Expanding Innovations, Inc. is a focused PatentsView assignee: 2 CPC subclasses with 83.3% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2018 (2 grants) versus a trough of 1 in 2020. By volume, Expanding sits between Exaptive, Inc. and EyePrint Prosthetics LLC.
Expanding's three-year grant acceleration
Expanding Innovations, Inc. shows 3 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Expanding's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Exaptive
Exaptive, Inc.
6 patents
- Exeltis USA
Exeltis USA, Inc.
6 patents
- Exotoe
ExoToe LLC
6 patents
- Exosite
Exosite LLC
6 patents
- Expedera
Expedera, Inc.
6 patents
- Exuma Biotech
Exuma Biotech Corp.
6 patents
- Eyegate Pharmaceu…
EyeGate Pharmaceuticals, Inc.
6 patents
- Eyeprint Prosthet…
EyePrint Prosthetics LLC
6 patents
- Expanding Innovat… ◀
Expanding Innovations, Inc.
6 patents
What this shows Expanding holds 6 patents at rank #40,134, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Expanding
By rank, the assignees closest to #40,134 in granted patent volume.
- Exaptive, Inc. #40,130 · 6 patents
- Exeltis USA, Inc. #40,131 · 6 patents
- ExoToe LLC #40,132 · 6 patents
- Exosite LLC #40,133 · 6 patents
- Expedera, Inc. #40,135 · 6 patents
- Exuma Biotech Corp. #40,136 · 6 patents
- EyeGate Pharmaceuticals, Inc. #40,137 · 6 patents
- EyePrint Prosthetics LLC #40,138 · 6 patents
Leaders in A61F (Filters Implantable Into Blood Vessels)
Other assignees with the most granted patents in Expanding's primary technology class.
- The Procter & Gamble Company 1,426 in class
- Boston Scientific Scimed, Inc. 1,101 in class
- Edwards Lifesciences Corporation 1,101 in class
- DePuy Synthes Products, Inc. 851 in class
- Globus Medical, Inc. 752 in class
- Cook Medical Technologies LLC 700 in class
- Smith & Nephew, Inc. 541 in class
- Covidien LP 528 in class
Expanding's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
41 Top 34% higher than 66% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 2 | 33.3% |
| 2020 | 1 | 16.7% |
| 2022 | 1 | 16.7% |
| 2023 | 2 | 33.3% |
Which technologies does Expanding Innovations, Inc. patent most?
Top 2 of 2 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Expanding Innovations, Inc.'s patent record in context - here's where to go next.
- Expanding Innovations, Inc.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 83.3% of its portfolio - see every assignee active in that class. Explore A61F
- Ranked #40,141 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Expanding Innovations, Inc. against Exaptive, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 41.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.